Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

B&L in Brazil

This article was originally published in The Gray Sheet

Executive Summary

Bausch & Lomb may delay filing its third-quarter financial statement with SEC after learning that a Brazilian subsidiary, BL Industria Otica (BLIO), likely engaged in illegal accounting practices. According to an ongoing investigation by Bausch & Lomb, BLIO's senior management mischaracterized about $600,000 in expenses to fund an unauthorized $1.5 mil. pension agreement. The company has also learned that Brazilian tax authorities are seeking roughly $5 mil. in unpaid taxes from the subsidiary. During B&L's Oct. 26 earnings call, the company declined to speculate when the case might be resolved. The firm stresses that BLIO accounted for $20 mil. in net sales in 2004, less than 1% of the company's consolidated revenues...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022825

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel